SCHEDULE 13D
SCHEDULE 13DSchedule 13D ownership disclosure
ENZO BIOCHEM INC
Common Stock, par value $0.01 per share · CUSIP: 294100102
Event date: 2025-06-23
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Battery Ventures XIV, L.P.Reported CIK 0001912746
Shares: 11,575,824.00 · Class: 21.8%
- Battery Ventures XIV-EF, L.P.Reported CIK 0001932594
Shares: 11,575,824.00 · Class: 21.8%
- Battery Investment Partners XIV, L.P.Reported CIK 0001913935
Shares: 11,575,824.00 · Class: 21.8%
- Battery Partners XIV, L.P.
Shares: 11,575,824.00 · Class: 21.8%
- Battery Partners GP XIV, LLC
Shares: 11,575,824.00 · Class: 21.8%
- Neeraj AgrawalReported CIK 0001532809
Shares: 11,575,824.00 · Class: 21.8%
- Michael M. BrownReported CIK 0001354614
Shares: 11,575,824.00 · Class: 21.8%
- Morad ElhafedReported CIK 0001869518
Shares: 11,575,824.00 · Class: 21.8%
- Jesse FeldmanReported CIK 0001568322
Shares: 11,575,824.00 · Class: 21.8%
- Russell L. FleischerReported CIK 0001108424
Shares: 11,575,824.00 · Class: 21.8%
- Roger H. LeeReported CIK 0001404868
Shares: 11,575,824.00 · Class: 21.8%
- Zachary Smotherman
Shares: 11,575,824.00 · Class: 21.8%
- Chelsea R. StonerReported CIK 0001741527
Shares: 11,575,824.00 · Class: 21.8%
- Dharmesh ThakkerReported CIK 0001869544
Shares: 11,575,824.00 · Class: 21.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-018509
- Form type
- SCHEDULE 13D
- Filer
- Battery Ventures XIV, L.P.
- CIK
- CIK 1912746
- Filed
- Jun 30, 2025
- Reporting period
- Jun 23, 2025
- Description
- Schedule 13D beneficial ownership